Navigation Links
China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
Date:11/10/2008

mpany's Slim Patch products early this year.

On October 28, 2008, China Sky One Medical reached a purchase agreement for a proprietary breast drug from Harbin Medical University for approximately $1.46 million. The Company collaborated with Harbin Medical University to develop the drug, which is intended to treat lobular hyperplasia in women, a type of mastitis that may lead to breast cancer. First phase clinical trials have been completed, and the drug has been shown to be 100% effective, with an 89% curability rate. Following the completion of additional clinical trials, the Company expects to obtain production approval for the drug from the SFDA in two to three years after the purchase is complete.

On October 30, 2008, the China Sky One Medical announced that it obtained production approval from the SFDA in China for two of its newly developed drugs, sodium ferulate by injection and doxofylline by injection. Sodium ferulate by injection is intended for the treatment of cardiovascular disease. Doxofylline by injection is intended for the treatment of asthma and bronchitis.

Business Outlook

"Despite the recent turmoil in the global economy, China Sky One continues to experience very strong demand for our pharmaceutical products. We have a rich pipeline of new products that are in the process of seeking SFDA approval, including external use TCM products, drugs for injection, diagnostic kits and biological pharmaceutical products. In addition, our very strong balance sheet and cash flows provide the flexibility to pursue additional acquisitions that can further strengthen our market position," said Mr. Yan-Qing Liu. "As a result of the synergies we will realize from our strategic acquisitions, and by focusing on developing high-quality products and expanding our sales and marketing efforts globally, we expect to see a significant increase in our top- and bottom-line performance in 2009 and beyond."

As a result of both strong organic
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
2. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008
3. TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China
4. China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26
5. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter 2009 Financial Results
6. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
7. China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination
8. China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
9. China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions
10. Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008
11. China Sky One Medical, Inc. Receives Tax Refund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... EMBARGOED FOR RELEASE UNTIL 2 P.M. ET, WEDNESDAY, ... of Mother’s Home to Gas Wells , PITTSBURGH, June 3, ... of natural gas wells drilled with hydraulic fracturing were more ... living farther from such wells, according to a University ... southwestern Pennsylvania birth records. , The finding does not ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 ... agreed to pay $7.8 million to resolve a Risperdal ... Arkansas over tactics the company allegedly used to market ... County Circuit Court indicate that the Arkansas Attorney General ... part of the accord. The Risperdal settlement amounts to ...
(Date:6/3/2015)... 2015 Follow us on LinkedIn ... revolutionized disease treatment on account of their better mode ... such as rheumatoid arthritis. The industry is expected to ... small molecule drugs to biopharmaceuticals over the coming years. ... and gene therapies, and recombinant proteins has attracted industry ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Dr. Steven Reisman, ... Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, announced ... weekdays to his practice. In most cases, depending on the ... the day they call, they will be seen by a ... priority as a cardiologist is to ensure that people who ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 ... strategic partnership to expand online and mobile access ... Board Review and Maintenance of Certification (MOC) activities. ... will market VeoMed’s innovative courses to Decker’s extensive ... professionals interested in purchasing access to VeoMed’s premier ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... The Sanitizer, Game Allows Consumers to Zap Germs in the Water Just ... ... 20 Just in time for Memorial Day,integrated marketing communications agency, Fletcher ... BioGuard,s new UV sanitizing unit, BioLab UV ( http://www.biolabuv.com ). ...
... is a well known disease entity that has a wide ... the colonic blood supply is key to its development. However, ... causes ischemia of the bowel. This report describes the first ... and splenic veins. , This case report, from a ...
... not uncommon to find tissue that normally lines the stomach ... tissue has been identified in such diverse locations as the ... case, reported by a team led by Dr. Steven Paul ... the World Journal of Gastroenterology. , Typically, when this gastric ...
... no obvious effects on MKN-45 cells proliferation and apoptosis. At ... apoptosis improved. It may be that CO2 gas affected the ... by a team led by Professor Pei-Wu Yu. The research ... World Journal of Gastroenterology. , There is an ongoing debate ...
... and calm, according to a new study from the Population ... at about age 60, participants reported more feelings of ease ... John Mirowsky, professors of sociology, have published the findings in ... issue of Social Science and Medicine. The research was funded ...
... substantial financial income and the ... chance to change people,s lives, ... so,people are increasingly looking for new ways to make the ... Today, that,s,possible with the independent marketing opportunities provided by,Melaleuca, The ...
Cached Medicine News:Health News:Fletcher Martin Creates Interactive Game-Ad for BioLab(R) UV for BioGuard(R) 2Health News:Heterotopic gastric tissue simulating acute appendicitis 2Health News:With age comes a sense of peace and calm 2Health News:Lucrative Sales Opportunities Abound With Melaleuca, The Wellness Company(R) 2
(Date:6/3/2015)... 3, 2015  Giving people with low vision hope ... the International Academy of Low Vision Specialists ... are at the forefront of low vision care. The ... technology and latest treatment options available to patients who ... with traditional means. Recently, doctors in six new states ...
(Date:6/3/2015)... 2015  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ... immunotherapies, today announced that it has entered into ... purchase approximately $13.6 million of securities in a ... to such investors an aggregate of 2,469,091 shares ... $5.50 per share. The gross ...
(Date:6/3/2015)... The treatment pipeline for Acute ... GBI Research . ... Myeloid Leukemia Therapeutics Market to 2020 - forecasts the ... from $632.6 million in 2013 to $878.6 million by 2020, ... Several drugs to treat AML are expected to be ...
Breaking Medicine Technology:International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4OncoSec Medical Announces $13.6 Million Registered Direct Offering 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 3Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: